Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Safety of PDT-Photofrin® Prior to Lung Surgery

ClinicalTrials.gov ID: NCT03344861

Public ClinicalTrials.gov record NCT03344861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Prospective, Open-label, Non-randomized Single-arm Clinical Study of the Safety and Tissue Response to Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Solid Lung Tumor Prior to Surgical Resection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is being conducted to assess the safety of PDT in subjects with peripherally located malignant tumors in lung parenchyma prior to surgical resection. It will involve up to 10 sites in USA. Participation will last 4 months.

Study identification

NCT ID
NCT03344861
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Concordia Laboratories Inc.
Industry
Enrollment
10 participants

Conditions and interventions

Interventions

Drug · Device

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 13, 2017
Primary completion
Mar 21, 2019
Completion
Mar 21, 2019
Last update posted
Jan 12, 2020

2017 – 2019

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048
University of Colorado Denver Colorado 80045
Moffitt Cancer Center Tampa Florida 33612
Cancer Treatment Centers of America/Southeastern Atlanta Georgia 30265
AMITA Health Alexian Brothers Medical Center Elk Grove Village Illinois 60007
Dubois Medical Center DuBois Pennsylvania 15801
UT MD Anderson Cancer Center Houston Texas 77030
Providence Health & Services Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03344861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03344861 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →